ADC is a promising imaging biomarker that can help differentiate succinate dehydrogenase mutation-positive from mutation-negative paragangliomas in the head and neck.
No takes yet. Share an insight, caveat, or question.
Rottensteiner et al. (2003) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: